Prospective gas chromatographic and spectrometric analysis of the exhalation of healthy test persons and of SARS-CoV2 infected patients as well as of patients suffering from COVID-19 at the Klinikum Dortmund

Recruiting

• Conditions: U07.1; COVID-19, virus identified

• Registration Number: DRKS00021399
• Lead Sponsor: Klinik für Neurochirurgie Klinikum Dortmund

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 450

Inclusion Criteria

test persons are lung healthy volunteers employed at the Klinikum Dortmund; due to the quarantaine zone it will not be possible to include non-employees
SARS-CoV2 infected patients and patients suffering from COVID-19, tested and treated at the Klinikum Dortmund, will be asked for participation irrespective of age and gender

Exclusion Criteria

test persons with a proven infection with SARS-CoV2, even though the infection might be dected >14d before, cannot be included;
test persons and patients with any proven infection of the respiratory tract within 4 weeks aside from SARS-CoV2, neoplasia or chronic respiratory or pulmonary illnesses are excluded.
test persons or patients in need of inhalative medication or medication targeted on the lung or respiratory tract are excluded

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
identification of a characteristic index of SARS-CoV2 in the gas chromatography / ionic motility spectrometer<br>

Secondary Outcome Measures

Name	Time	Method
quantitative assessment of the viral load at different points during the course of the infection with SARS-CoV2<br>a) patients infected without signs of COVID-19<br>b) patient suffering from COVID-19